Yubo Financial Statements From 2010 to 2025
| YBGJ Stock | USD 0.07 0.0001 0.15% |
Check Yubo International financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Yubo International's main balance sheet or income statement drivers, such as , as well as many indicators such as . Yubo financial statements analysis is a perfect complement when working with Yubo International Valuation or Volatility modules.
Yubo |
Yubo International Biotech Company Shares Owned By Insiders Analysis
Yubo International's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Yubo International Shares Owned By Insiders | 95.45 % |
Most of Yubo International's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Yubo International Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 95% of Yubo International Biotech are shares owned by insiders. This is much higher than that of the Healthcare sector and notably higher than that of the Medical Instruments & Supplies industry. The shares owned by insiders for all United States stocks is notably lower than that of the firm.
Yubo International Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Yubo International's current stock value. Our valuation model uses many indicators to compare Yubo International value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Yubo International competition to find correlations between indicators driving Yubo International's intrinsic value. More Info.Yubo International Biotech is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Yubo International's earnings, one of the primary drivers of an investment's value.About Yubo International Financial Statements
Investors use fundamental indicators, such as Yubo International's revenue or net income, to determine how well the company is positioned to perform in the future. Although Yubo International's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Yubo International Biotech Limited, thorough its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. Yubo Intl is traded on OTC Exchange in the United States.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Yubo Pink Sheet
Yubo International financial ratios help investors to determine whether Yubo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Yubo with respect to the benefits of owning Yubo International security.